Skip to content

NBTX

Nanobiotix SA

NASDAQ · Healthcare · Biotechnology · FR

$33.05
−7.89%
Ask drillr

Margins

Gross margin
100.0%
EBITDA margin
-40.7%
EBIT margin
-36.5%
Net margin
-80.8%
FCF margin
-114.6%
28.4%
Return on equity
-35.4%
Return on assets
-99.8%
Return on invested capital
0.52x
Asset turnover
-$38.4M
Cash from operations
$1.19
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025